CRNX

Crinetics Pharmaceuticals
CRNX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$3.01B
EV
$1.71B
Shares Outstanding
95.50M
Beta
0.37

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$75.36
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Crinetics Pharmaceuticals, Inc.

gainify
CRNX

Crinetics Pharmaceuticals, Inc.

CRNX

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company’s lead product candidate is paltusotine, ...

Sector

Healthcare

Industry

Biotechnology

CEO

Struthers, R.

Employees

437

IPO Date

2018-07-18

Headquarters

6055 Lusk Boulevard, San Diego, California, 92121, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved